199 related articles for article (PubMed ID: 33649182)
1. Genome wide association study of HTLV-1-associated myelopathy/tropical spastic paraparesis in the Japanese population.
Penova M; Kawaguchi S; Yasunaga JI; Kawaguchi T; Sato T; Takahashi M; Shimizu M; Saito M; Tsukasaki K; Nakagawa M; Takenouchi N; Hara H; Matsuura E; Nozuma S; Takashima H; Izumo S; Watanabe T; Uchimaru K; Iwanaga M; Utsunomiya A; Tabara Y; Paul R; Yamano Y; Matsuoka M; Matsuda F
Proc Natl Acad Sci U S A; 2021 Mar; 118(11):. PubMed ID: 33649182
[TBL] [Abstract][Full Text] [Related]
2. HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy.
Jeffery KJ; Usuku K; Hall SE; Matsumoto W; Taylor GP; Procter J; Bunce M; Ogg GS; Welsh KI; Weber JN; Lloyd AL; Nowak MA; Nagai M; Kodama D; Izumo S; Osame M; Bangham CR
Proc Natl Acad Sci U S A; 1999 Mar; 96(7):3848-53. PubMed ID: 10097126
[TBL] [Abstract][Full Text] [Related]
3. Putative role of HLA polymorphism among a Brazilian HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) population.
Schor D; Porto LC; Roma EH; Castro-Alves J; Villela AP; Araújo AQC; Glória Bonecini-Almeida M
Sci Rep; 2023 May; 13(1):7659. PubMed ID: 37169817
[TBL] [Abstract][Full Text] [Related]
4. The influence of HLA class I alleles and heterozygosity on the outcome of human T cell lymphotropic virus type I infection.
Jeffery KJ; Siddiqui AA; Bunce M; Lloyd AL; Vine AM; Witkover AD; Izumo S; Usuku K; Welsh KI; Osame M; Bangham CR
J Immunol; 2000 Dec; 165(12):7278-84. PubMed ID: 11120862
[TBL] [Abstract][Full Text] [Related]
5. Possible implication of NFKB1A and NKG2D genes in susceptibility to HTLV-1-associated myelopathy/tropical spastic paraparesis in Peruvian patients infected with HTLV-1.
Talledo M; López G; Huyghe JR; Verdonck K; González E; Clark D; Vanham G; Gotuzzo E; Van Camp G; Van Laer L
J Med Virol; 2012 Feb; 84(2):319-26. PubMed ID: 22170554
[TBL] [Abstract][Full Text] [Related]
6. Association between HLA-DRB1*01 and HLA-Cw*08 and outcome following HTLV-I infection.
Rafatpanah H; Pravica V; Faridhosseini R; Tabatabaei A; Ollier W; Poulton K; Thomson W; Hutchinson I
Iran J Immunol; 2007 Jun; 4(2):94-100. PubMed ID: 17652849
[TBL] [Abstract][Full Text] [Related]
7. HLA-B*35 as a new marker for susceptibility to human T-cell lymphotropic virus type 1 (HTLV-1) Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) in patients living in Argentina.
Benencio P; Fraile Gonzalez SA; Ducasa N; Page K; Berini CA; Biglione MM
Retrovirology; 2020 Sep; 17(1):29. PubMed ID: 32883310
[TBL] [Abstract][Full Text] [Related]
8. Lack of association between single-nucleotide polymorphisms of pro- and anti-inflammatory cytokines and HTLV-1-associated myelopathy / tropical spastic paraparesis development in patients from Rio de Janeiro, Brazil.
Schor D; Porto LC; Roma EH; Quintana MSB; Fabricio-Silva GM; Bonecini-Almeida MG; Araújo AQ; Andrada-Serpa MJ
BMC Infect Dis; 2018 Nov; 18(1):593. PubMed ID: 30466392
[TBL] [Abstract][Full Text] [Related]
9. The effect of HTLV-1 virulence factors (HBZ, Tax, proviral load), HLA class I and plasma neopterin on manifestation of HTLV-1 associated myelopathy tropical spastic paraparesis.
Tarokhian H; Taghadosi M; Rafatpanah H; Rajaei T; Azarpazhooh MR; Valizadeh N; Rezaee SAR
Virus Res; 2017 Jan; 228():1-6. PubMed ID: 27845163
[TBL] [Abstract][Full Text] [Related]
10. Association between HLA alleles and HAM/TSP in individuals infected with HTLV-1.
Treviño A; Vicario JL; Lopez M; Parra P; Benito R; Ortiz de Lejarazu R; Ramos JM; Del Romero J; de Mendoza C; Soriano V
J Neurol; 2013 Oct; 260(10):2551-5. PubMed ID: 23835632
[TBL] [Abstract][Full Text] [Related]
11. Clinical symptoms and the odds of human T-cell lymphotropic virus type 1-associated myelopathy/ tropical spastic paraparesis (HAM/TSP) in healthy virus carriers: application of best-fit logistic regression equation based on host genotype, age, and provirus load.
Nose H; Saito M; Usuku K; Sabouri AH; Matsuzaki T; Kubota R; Eiraku N; Furukawa Y; Izumo S; Arimura K; Osame M
J Neurovirol; 2006 Jun; 12(3):171-7. PubMed ID: 16877298
[TBL] [Abstract][Full Text] [Related]
12. HTLV-1 proviral integration sites differ between asymptomatic carriers and patients with HAM/TSP.
Niederer HA; Laydon DJ; Melamed A; Elemans M; Asquith B; Matsuoka M; Bangham CR
Virol J; 2014 Sep; 11():172. PubMed ID: 25270762
[TBL] [Abstract][Full Text] [Related]
13. Differences in viral and host genetic risk factors for development of human T-cell lymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis between Iranian and Japanese HTLV-1-infected individuals.
Sabouri AH; Saito M; Usuku K; Bajestan SN; Mahmoudi M; Forughipour M; Sabouri Z; Abbaspour Z; Goharjoo ME; Khayami E; Hasani A; Izumo S; Arimura K; Farid R; Osame M
J Gen Virol; 2005 Mar; 86(Pt 3):773-781. PubMed ID: 15722539
[TBL] [Abstract][Full Text] [Related]
14. SYBR Green-based quantitation of human T-lymphotropic virus type 1 proviral load in Peruvian patients with neurological disease and asymptomatic carriers: influence of clinical status, sex, and familial relatedness.
Adaui V; Verdonck K; Best I; González E; Tipismana M; Arévalo J; Vanham G; Campos M; Zimic M; Gotuzzo E
J Neurovirol; 2006 Dec; 12(6):456-65. PubMed ID: 17162661
[TBL] [Abstract][Full Text] [Related]
15. Polygenic control of human T lymphotropic virus type I (HTLV-I) provirus load and the risk of HTLV-I-associated myelopathy/tropical spastic paraparesis.
Vine AM; Witkover AD; Lloyd AL; Jeffery KJ; Siddiqui A; Marshall SE; Bunce M; Eiraku N; Izumo S; Usuku K; Osame M; Bangham CR
J Infect Dis; 2002 Oct; 186(7):932-9. PubMed ID: 12232833
[TBL] [Abstract][Full Text] [Related]
16. Monitoring the HTLV-1 proviral load in the peripheral blood of asymptomatic carriers and patients with HTLV-associated myelopathy/tropical spastic paraparesis from a Brazilian cohort: ROC curve analysis to establish the threshold for risk disease.
Furtado Mdos S; Andrade RG; Romanelli LC; Ribeiro MA; Ribas JG; Torres EB; Barbosa-Stancioli EF; Proietti AB; Martins ML
J Med Virol; 2012 Apr; 84(4):664-71. PubMed ID: 22337307
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of host genetic and viral factors as surrogate markers for HTLV-1-associated myelopathy/tropical spastic paraparesis in Peruvian HTLV-1-infected patients.
Talledo M; López G; Huyghe JR; Verdonck K; Adaui V; González E; Best I; Clark D; Vanham G; Gotuzzo E; Van Camp G; Van Laer L
J Med Virol; 2010 Mar; 82(3):460-6. PubMed ID: 20087941
[TBL] [Abstract][Full Text] [Related]
18. HLA-G 3'-untranslated region polymorphisms are associated with HTLV-1 infection, proviral load and HTLV-associated myelopathy/tropical spastic paraparesis development.
Cilião Alves DC; Haddad R; Rocha-Júnior MC; de Deus Wagatsuma VM; Martelli-Palomino G; Marques AA; Takayanagui OM; Covas DT; Kashima S; Donadi EA
J Gen Virol; 2016 Oct; 97(10):2742-2752. PubMed ID: 27449667
[TBL] [Abstract][Full Text] [Related]
19. Proviral load and immune markers associated with human T-lymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Peru.
Best I; Adaui V; Verdonck K; González E; Tipismana M; Clark D; Gotuzzo E; Vanham G
Clin Exp Immunol; 2006 Nov; 146(2):226-33. PubMed ID: 17034574
[TBL] [Abstract][Full Text] [Related]
20. High HTLV-1 proviral load, a marker for HTLV-1 associated myelopathy/tropical spastic paraparesis, is also detected in patients with infective dermatitis associated with HTLV-1.
Primo J; Siqueira I; Nascimento MC; Oliveira MF; Farre L; Carvalho EM; Bittencourt AL
Braz J Med Biol Res; 2009 Aug; 42(8):761-4. PubMed ID: 19578703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]